Showing 841 - 860 results of 230,837 for search '(( 10 ((a decrease) OR (mean decrease)) ) OR ( 5 ((a decrease) OR (mean decrease)) ))', query time: 1.40s Refine Results
  1. 841
  2. 842
  3. 843
  4. 844
  5. 845

    Decreased neurogenesis and impaired PPI in MAM-treated wild-type rats. by Motoko Maekawa (36394)

    Published 2009
    “…(B), The number of BrdU-positive cells was decreased to 63% in the DG of MAM (10 mg/kg)-treated wild-type rats at 5 week, but did not differ between the two groups at 10 weeks of age. n.s., not significant. …”
  6. 846

    A homozygous point mutation in the <i>Mrps34</i> gene causes a decrease in the MRPS34 protein. by Tara R. Richman (713532)

    Published 2015
    “…The 5′- and 3′-untranslated regions are shown as grey boxes and the predicted mitochondrial targeting sequence is shown as a black box (predicted using MitoProtII, [<a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1005089#pgen.1005089.ref040" target="_blank">40</a>]). …”
  7. 847
  8. 848
  9. 849
  10. 850

    Inhibition of MRP1 significantly decreases basal and apoptotic GSH efflux. by Parameswaran G. Sreekumar (176748)

    Published 2012
    “…GSH release from MRP1-silenced ARPE-19 cells incubated with 150 µM H<sub>2</sub>O<sub>2</sub> for 5 h in serum free medium. A significant decrease (P<0.001 vs scrambled control) in GSH release was observed in 5 h. …”
  11. 851
  12. 852
  13. 853
  14. 854
  15. 855
  16. 856
  17. 857
  18. 858
  19. 859
  20. 860

    Pro-apoptotic markers are decreased after IGFBP-3 NB injections. by Youde Jiang (436930)

    Published 2014
    “…<p>For all studies, groups are control (ctrl), diabetic (Diabetic), Diabetic +IGFBP-3 NB (Diab +BP3), Diabetic +CMV (Diab+CMV), Diabetic+IGFBP-3 NB left eye (Diab+BP3 contra) and Diabetic+CMV left eye (Diab+CMV Contra). Panels A&B show that Bax (A) and cleaved caspase 3 (B) levels are all decreased after the IGFBP-3 NB intravitreal injections. …”